Compare IMTX & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMTX | CNMD |
|---|---|---|
| Founded | N/A | 1970 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | N/A | 1987 |
| Metric | IMTX | CNMD |
|---|---|---|
| Price | $10.34 | $40.36 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | $19.25 | ★ $53.67 |
| AVG Volume (30 Days) | 623.6K | ★ 669.5K |
| Earning Date | 11-17-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 2.00% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.05 |
| Revenue | $99,445,031.00 | ★ $1,347,470,000.00 |
| Revenue This Year | N/A | $6.81 |
| Revenue Next Year | $24.39 | $5.23 |
| P/E Ratio | ★ N/A | $19.49 |
| Revenue Growth | N/A | ★ 4.61 |
| 52 Week Low | $3.30 | $38.32 |
| 52 Week High | $12.41 | $74.70 |
| Indicator | IMTX | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 52.53 | 42.61 |
| Support Level | $9.52 | $38.65 |
| Resistance Level | $10.24 | $40.81 |
| Average True Range (ATR) | 0.68 | 1.63 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 28.72 | 28.70 |
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.